|
Catalog Number E100-27M |
Device Problem
Patient-Device Incompatibility (2682)
|
Patient Problem
Dyspnea (1816)
|
Event Date 11/13/2023 |
Event Type
Injury
|
Event Description
|
It was reported that on (b)(6) 2020, a 27mm epic mitral valve was implanted in a patient.On (b)(6) 2023, the valve failure discovered, the patient has shortness of breath with movement.On (b)(6) 2020, the valve was explanted.Upon explant, there was pannus observed on the valve.The patient is stable.
|
|
Manufacturer Narrative
|
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Na.
|
|
Manufacturer Narrative
|
Explant of the device due to stenosis and pannus was reported.The device was received for investigation which found that there was fibrous thickening on cusps 1 and 3.The majority of the cusp tissue was previously removed or torn.There was pannus on the outflow of cusp 3 which was limited to the sewing cuff.Folds/retractions were present in cusp 1.No inflammation or significant calcifications were present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The pannus reported could have contributed to the stenosis reported, however with the majority of the tissue not being present for analysis this could not be confirmed.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
|
|
Manufacturer Narrative
|
Explant of the device due to stenosis and pannus was reported.The device was received for investigation which found that there was fibrous thickening on cusps 1 and 3.The majority of the cusp tissue was previously removed or torn.There was pannus on the outflow of cusp 3 which was limited to the sewing cuff.Folds/retractions were present in cusp 1.No inflammation or significant calcifications were present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The pannus reported could have contributed to the stenosis reported, however with the majority of the tissue not being present for analysis this could not be confirmed.There is no indication of a product quality issue with regards to manufacture, design, or labeling.It was reported that on (b)(6) 2020, a 27mm epic mitral valve was implanted in a patient.On (b)(6) 2023, the valve failure discovered, the patient has shortness of breath with movement.On (b)(6) 2023, the valve was explanted.Upon explant, there was pannus observed on the valve.The patient is stable.
|
|
Event Description
|
N/a.
|
|
Search Alerts/Recalls
|
|
|